A systematic review and analysis of long-term growth trials on the effect of diet on omega-3 fatty acid levels in the fillet tissue of post-smolt Atlantic salmon

Elucidating the specific effects of diet on the fatty acid composition in Atlantic salmon (Salmo salar), particularly health beneficial omega-3 long-chain polyunsaturated fatty acids (n-3 LC PUFA), remains an area of intense commercial interest given the increasing market restrictions placed on the supply of fishmeal and fish oil. The present study conducted a systematic review and subsequent analysis of published nutritional data from long-term growth trials using post-smolt Atlantic salmon to provide a summary of currently available information and to identify the most significant drivers of omega-3 levels in Atlantic salmon fillet tissue. Overall, there were relatively few studies which met the selection criteria and this had implications for further explanation of some results. Statistically significant regression models were generated for fillet DHA and fillet n-3 LC PUFA. Fish weight was a significant predictor in both models, and dietary 22:6n-3 (DHA) was an intuitive predictor of fillet DHA. Furthermore, dietary EPA and dietary 22:1 isomers were significant predictors of fillet n-3 LC PUFA

公众参与消防安全建设:路径选择与制度供给

消防安全是公共安全的重要组成部分,公众参与消防安全建设是消防安全管理工作的内在需求和必然趋势。积极探索公众参与消防安全建设的具体路径,为公民参与消防建设提供制度保障是当前消防管理工作的重要课题。本文力图从消防政策的制定与监督、社会化的消防工作网络、依托社会的消防教育三个方面构建以政府为主导的公民参与消防安全建设的路径,并为这些参与途径设计了以信息公开及法制建设为基础,以增强民间组织参与能力为目标,以经济、文化等各种手段为支持的公众参与消防建设的制度框架

GW501516, a PPARδ Agonist, Ameliorates Tubulointerstitial Inflammation in Proteinuric Kidney Disease via Inhibition of TAK1-NFκB Pathway in Mice

Peroxisome proliferator-activated receptors (PPARs) are a nuclear receptor family of ligand-inducible transcription factors, which have three different isoforms: PPARα, δ and γ. It has been demonstrated that PPARα and γ agonists have renoprotective effects in proteinuric kidney diseases; however, the role of PPARδ agonists in kidney diseases remains unclear. Thus, we examined the renoprotective effect of GW501516, a PPARδ agonist, in a protein-overload mouse nephropathy model and identified its molecular mechanism. Mice fed with a control diet or GW501516-containing diet were intraperitoneally injected with free fatty acid (FFA)-bound albumin or PBS(−). In the control group, protein overload caused tubular damages, macrophage infiltration and increased mRNA expression of MCP-1 and TNFα. These effects were prevented by GW501516 treatment. In proteinuric kidney diseases, excess exposure of proximal tubular cells to albumin, FFA bound to albumin or cytokines such as TNFα is detrimental. In vitro studies using cultured proximal tubular cells showed that GW501516 attenuated both TNFα- and FFA (palmitate)-induced, but not albumin-induced, MCP-1 expression via direct inhibition of the TGF-β activated kinase 1 (TAK1)-NFκB pathway, a common downstream signaling pathway to TNFα receptor and toll-like receptor-4. In conclusion, we demonstrate that GW501516 has an anti-inflammatory effect in renal tubular cells and may serve as a therapeutic candidate to attenuate tubulointerstitial lesions in proteinuric kidney diseases